Vitamin D Receptor Activation Reduces Hepatic Inflammation via Enhancing Macrophage Autophagy in Cholestatic Mice
The American Journal of Pathology · 2024
DOI: 10.1016/j.ajpath.2023.11.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2024. Verfasst von Tianfu Wen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Affiliated Wenling First People's Hospital, Taizhou University, Taizhou, China. Hauptthemen laut MEDLINE: Cholestasis, Inflammasomes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, Science and Technology Department of Zhejiang Province.
Abstract (Originalsprache)
Macrophage autophagy dysfunction aggravates liver injury by activating inflammasomes, which can cleave pro-IL-1β to its active, secreted form. We investigated whether the vitamin D/vitamin D receptor (VDR) axis could up-regulate macrophage autophagy function to inhibit the activation of inflammasome-dependent IL-1β during cholestasis. Paricalcitol (PAL; VDR agonist) was intraperitoneally injected into bile duct-ligated mice for 5 days. Up-regulation of VDR expression by PAL reduced liver injury by reducing the oxidative stress-induced inflammatory reaction in macrophages. Moreover, PAL inhibited inflammasome-dependent IL-1β generation. Mechanistically, the knockdown of VDR increased IL-1β generation, whereas VDR overexpression exerted the opposite effect following tert-butyl hydroperoxide treatment. The inflammasome antagonist glyburide, the caspase-1-specific inhibitor YVAD, and the reactive oxygen species (ROS) scavenger N-acetyl-l-cysteine (NAC) blocked the increase in Vdr shRNA-induced IL-1β production. Interestingly, up-regulation of VDR also enhanced macrophage autophagy. Autophagy reduction impaired the up-regulation of VDR-inhibited macrophage inflammasome-generated IL-1β, whereas autophagy induction showed a synergistic effect with VDR overexpression through ROS-p38 mitogen-activated protein kinase (MAPK) pathway. This result was confirmed by p38 MAPK inhibitor, MAPK activator, and ROS inhibitor NAC. Collectively, PAL triggered macrophage autophagy by suppressing activation of the ROS-p38 MAPK pathway, which, in turn, suppressed inflammasome-generated cleaved, active forms of IL-1β, eventually leading to reduced inflammation. Thus, triggering the VDR may be a potential target for the anti-inflammatory treatment of cholestatic liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The Affiliated Wenling First People's Hospital, Taizhou University, Taizhou, China.
- Department of Cell Biology, School of Medicine, Taizhou University, Taizhou, China.
- Department of Pathophysiology, School of Basic Medicine, Shenyang Medical College, Shenyang, China.
- Department of Hematology, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
- Department of General Surgery, The Affiliated Wenling First People's Hospital, Taizhou University, Taizhou, China. Electronic address: lilihua1018@sina.com.
Förderung
- Natural Science Foundation of Zhejiang Province
- Science and Technology Department of Zhejiang Province
Zitieren
APA
Wen, T., Xie, J., Ma, L., Hao, Z., Zhang, W., Wu, T., & Li, L. (2024). Vitamin D Receptor Activation Reduces Hepatic Inflammation via Enhancing Macrophage Autophagy in Cholestatic Mice. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2023.11.016
Vancouver
Wen T, Xie J, Ma L, Hao Z, Zhang W, Wu T, et al. Vitamin D Receptor Activation Reduces Hepatic Inflammation via Enhancing Macrophage Autophagy in Cholestatic Mice. The American Journal of Pathology. 2024. doi:10.1016/j.ajpath.2023.11.016
BibTeX
@article{Wen2024,
author = {Wen, Tianfu and Xie, Jing and Ma, Liman and Hao, Zhiqing and Zhang, Weiwei and Wu, Tingyao and Li, Lihua},
title = {Vitamin D Receptor Activation Reduces Hepatic Inflammation via Enhancing Macrophage Autophagy in Cholestatic Mice},
journal = {The American Journal of Pathology},
year = {2024},
doi = {10.1016/j.ajpath.2023.11.016}
}
EUVIMED